{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T06:45:17Z","timestamp":1789022717694,"version":"build-2803163510"},"reference-count":101,"publisher":"Elsevier","isbn-type":[{"value":"9780128123416","type":"print"}],"license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018]]},"DOI":"10.1016\/bs.pmbts.2017.12.010","type":"book-chapter","created":{"date-parts":[[2018,3,28]],"date-time":"2018-03-28T13:09:00Z","timestamp":1522242540000},"page":"355-382","source":"Crossref","is-referenced-by-count":28,"title":["Gangliosides and Autoimmune Peripheral Nerve Diseases"],"prefix":"10.1016","author":[{"given":"John A.","family":"Goodfellow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugh J.","family":"Willison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"14","key":"10.1016\/bs.pmbts.2017.12.010_bib0510","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1002\/glia.20750","article-title":"Molecular domains of myelinated axons in the peripheral nervous system","volume":"56","author":"Salzer","year":"2008","journal-title":"Glia"},{"issue":"1","key":"10.1016\/bs.pmbts.2017.12.010_bib0515","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1529-8027.2002.02001.x","article-title":"Recent progress on the molecular organization of myelinated axons","volume":"7","author":"Scherer","year":"2002","journal-title":"J Peripher Nerv Syst"},{"issue":"Pt. 3","key":"10.1016\/bs.pmbts.2017.12.010_bib0520","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1093\/brain\/122.3.449","article-title":"The distribution of ganglioside-like moieties in peripheral nerves","volume":"122","author":"Sheikh","year":"1999","journal-title":"Brain"},{"issue":"5","key":"10.1016\/bs.pmbts.2017.12.010_bib0525","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/01.wco.0000245365.51823.72","article-title":"Immune circuitry in the peripheral nervous system","volume":"19","author":"Kieseier","year":"2006","journal-title":"Curr Opin Neurol"},{"issue":"1","key":"10.1016\/bs.pmbts.2017.12.010_bib0530","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/mus.20893","article-title":"The immunocompetence of Schwann cells","volume":"37","author":"Meyer Zu","year":"2008","journal-title":"Muscle Nerve"},{"issue":"2","key":"10.1016\/bs.pmbts.2017.12.010_bib0535","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1136\/jnnp-2012-302312","article-title":"Biology of the blood-nerve barrier and its alteration in immune mediated neuropathies","volume":"84","author":"Kanda","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"10.1016\/bs.pmbts.2017.12.010_bib0540","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1023\/A:1022497114813","article-title":"Gangliosides and glycosphingolipids of peripheral nervous system myelins-a minireview","volume":"23","author":"Ogawa-Goto","year":"1998","journal-title":"Neurochem Res"},{"issue":"4","key":"10.1016\/bs.pmbts.2017.12.010_bib0545","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2183\/pjab.89.129","article-title":"Biosynthesis and biological function of sulfoglycolipids","volume":"89","author":"Honke","year":"2013","journal-title":"Proc Jpn Acad Ser B Phys Biol Sci"},{"issue":"4397","key":"10.1016\/bs.pmbts.2017.12.010_bib0550","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1126\/science.451555","article-title":"Experimental allergic neuritis induced by sensitization with galactocerebroside","volume":"204","author":"Saida","year":"1979","journal-title":"Science"},{"key":"10.1016\/bs.pmbts.2017.12.010_bib0555","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/978-1-4615-4685-6_19","article-title":"Genetic analysis of myelin galactolipid function","volume":"468","author":"Popko","year":"1999","journal-title":"Adv Exp Med Biol"},{"issue":"2","key":"10.1016\/bs.pmbts.2017.12.010_bib0560","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0005-2760(94)90034-5","article-title":"Gangliosides and allied glycosphingolipids in human peripheral nerve and spinal cord","volume":"1214","author":"Svennerholm","year":"1994","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"10.1016\/bs.pmbts.2017.12.010_bib0565","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0022-510X(02)00005-9","article-title":"Fine specificities of anti-LM1 IgG antibodies in Guillain\u2013Barre syndrome","volume":"195","author":"Susuki","year":"2002","journal-title":"J Neurol Sci"},{"issue":"1\u20132","key":"10.1016\/bs.pmbts.2017.12.010_bib0570","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jneuroim.2012.03.001","article-title":"Analysis of humoral immune responses to LM1 ganglioside in guinea pigs","volume":"246","author":"Gu","year":"2012","journal-title":"J Neuroimmunol"},{"issue":"25","key":"10.1016\/bs.pmbts.2017.12.010_bib0575","doi-asserted-by":"crossref","first-page":"11717","DOI":"10.1016\/S0021-9258(18)67303-X","article-title":"Structure of sulfated glucuronyl glycolipids in the nervous system reacting with HNK-1 antibody and some IgM paraproteins in neuropathy","volume":"261","author":"Chou","year":"1986","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/bs.pmbts.2017.12.010_bib0580","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0006-8993(86)91540-4","article-title":"Sulfated glucuronyl glycolipids reacting with anti-myelin-associated glycoprotein monoclonal antibodies including IgM paraproteins in neuropathy: species distribution and partial characterization of epitopes","volume":"385","author":"Ilyas","year":"1986","journal-title":"Brain Res"},{"issue":"2","key":"10.1016\/bs.pmbts.2017.12.010_bib0585","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/S0021-9258(19)75864-5","article-title":"Characterization of sulfated glucuronic acid containing glycolipids reacting with IgM M-proteins in patients with neuropathy","volume":"262","author":"Ariga","year":"1987","journal-title":"J Biol Chem"},{"key":"10.1016\/bs.pmbts.2017.12.010_bib0590","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0076-6879(82)83012-7","article-title":"Gangliosides: structure, isolation, and analysis","volume":"83","author":"Ledeen","year":"1982","journal-title":"Methods Enzymol"},{"issue":"11","key":"10.1016\/bs.pmbts.2017.12.010_bib0595","first-page":"1140","article-title":"Natural anti-carbohydrate antibodies contributing to evolutionary survival of primates in viral epidemics?","volume":"26","author":"Galili","year":"2016","journal-title":"Glycobiology"},{"issue":"16","key":"10.1016\/bs.pmbts.2017.12.010_bib0600","doi-asserted-by":"crossref","first-page":"6876","DOI":"10.1523\/JNEUROSCI.22-16-06876.2002","article-title":"Complex gangliosides at the neuromuscular junction are membrane receptors for autoantibodies and botulinum neurotoxin but redundant for normal synaptic function","volume":"22","author":"Bullens","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/bs.pmbts.2017.12.010_bib0605","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/B978-0-12-800097-7.00003-8","article-title":"Modulation of glycan recognition by clustered saccharide patches","volume":"308","author":"Cohen","year":"2014","journal-title":"Int Rev Cell Mol Biol"},{"issue":"Pt. 6","key":"10.1016\/bs.pmbts.2017.12.010_bib0610","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1093\/brain\/aww056","article-title":"Anti-ganglioside antibodies are removed from circulation in mice by neuronal endocytosis","volume":"139","author":"Cunningham","year":"2016","journal-title":"Brain"},{"issue":"1","key":"10.1016\/bs.pmbts.2017.12.010_bib0615","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/joa.12088","article-title":"The pre-synaptic motor nerve terminal as a site for antibody-mediated neurotoxicity in autoimmune neuropathies and synaptopathies","volume":"224","author":"Fewou","year":"2014","journal-title":"J Anatomy"},{"issue":"3","key":"10.1016\/bs.pmbts.2017.12.010_bib0620","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1172\/JCI59110","article-title":"Anti-ganglioside antibody internalization attenuates motor nerve terminal injury in a mouse model of acute motor axonal neuropathy","volume":"122","author":"Fewou","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/bs.pmbts.2017.12.010_bib0625","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jneuroim.2008.05.028","article-title":"The role of complement and complement regulators in mediating motor nerve terminal injury in murine models of Guillain\u2013Barre syndrome","volume":"201\u2013202","author":"Willison","year":"2008","journal-title":"J Neuroimmunol"},{"issue":"Pt. 12","key":"10.1016\/bs.pmbts.2017.12.010_bib0630","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1093\/brain\/awf272","article-title":"Peripheral neuropathies and anti-glycolipid antibodies","volume":"125","author":"Willison","year":"2002","journal-title":"Brain"},{"key":"10.1016\/bs.pmbts.2017.12.010_bib0635","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0140-6736(97)12308-X","article-title":"Guillain\u2013Barre syndrome","volume":"352","author":"Hahn","year":"1998","journal-title":"Lancet"},{"issue":"9497","key":"10.1016\/bs.pmbts.2017.12.010_bib0640","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/S0140-6736(05)67665-9","article-title":"Guillain\u2013Barre syndrome","volume":"366","author":"Hughes","year":"2005","journal-title":"Lancet"},{"issue":"10045","key":"10.1016\/bs.pmbts.2017.12.010_bib0645","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0140-6736(16)00339-1","article-title":"Guillain\u2013Barre syndrome","volume":"388","author":"Willison","year":"2016","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/bs.pmbts.2017.12.010_bib0650","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1473-3099(01)00019-6","article-title":"Infectious origins of, and molecular mimicry in, Guillain\u2013Barre and Fisher syndromes","volume":"1","author":"Yuki","year":"2001","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/bs.pmbts.2017.12.010_bib0655","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneuroim.2015.02.009","article-title":"Polyneuropathy with anti-sulfatide and anti-MAG antibodies: clinical, neurophysiological, pathological features and response to treatment","volume":"281","author":"Campagnolo","year":"2015","journal-title":"J Neuroimmunol"},{"issue":"suppl 1","key":"10.1016\/bs.pmbts.2017.12.010_bib0660","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1002\/ana.410370706","article-title":"Chronic motor neuropathies: diagnosis, therapy, and pathogenesis","volume":"37","author":"Kornberg","year":"1995","journal-title":"Ann Neurol"},{"issue":"Pt. 10","key":"10.1016\/bs.pmbts.2017.12.010_bib0665","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1093\/brain\/124.10.1968","article-title":"The clinical and laboratory features of chronic sensory ataxic neuropathy with anti-disialosyl IgM antibodies","volume":"124","author":"Willison","year":"2001","journal-title":"Brain"},{"issue":"6","key":"10.1016\/bs.pmbts.2017.12.010_bib0670","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/ana.410310619","article-title":"Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome","volume":"31","author":"Chiba","year":"1992","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/bs.pmbts.2017.12.010_bib0675","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.plipres.2009.09.001","article-title":"Heteromeric glycolipid complexes as modulators of autoantibody and lectin binding","volume":"49","author":"Rinaldi","year":"2010","journal-title":"Prog Lipid Res"},{"issue":"11","key":"10.1016\/bs.pmbts.2017.12.010_bib0680","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1136\/jnnp-2014-310097","article-title":"Nodopathies of the peripheral nerve: an emerging concept","volume":"86","author":"Uncini","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"10","key":"10.1016\/bs.pmbts.2017.12.010_bib0685","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1093\/brain\/awq260","article-title":"Conduction block in acute motor axonal neuropathy","volume":"133","author":"Kokubun","year":"2010","journal-title":"Brain"},{"issue":"1\u20132","key":"10.1016\/bs.pmbts.2017.12.010_bib0690","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jns.2013.11.016","article-title":"Clinical features in Guillain\u2013Barre syndrome with anti-Gal-C antibody","volume":"337","author":"Samukawa","year":"2014","journal-title":"J Neurol Sci"},{"issue":"4","key":"10.1016\/bs.pmbts.2017.12.010_bib0695","first-page":"413","article-title":"Immune-mediated neuropathy and anti-glycolipid antibodies","volume":"65","author":"Kaida","year":"2013","journal-title":"Brain Nerve"},{"key":"10.1016\/bs.pmbts.2017.12.010_bib0700","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1586\/14737175.2015.1065732","article-title":"Guillain-Barre syndrome","volume":"15","author":"Wakerley","year":"2015","journal-title":"Expert Rev Neurother"},{"issue":"7","key":"10.1016\/bs.pmbts.2017.12.010_bib0705","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1212\/WNL.54.7.1453","article-title":"Cross-reactive antibodies against GM2 and CMV-infected fibroblasts in Guillain\u2013Barre syndrome","volume":"54","author":"Ang","year":"2000","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/bs.pmbts.2017.12.010_bib0710","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/jns5.12011","article-title":"Anti-GM2 ganglioside antibodies are a biomarker for acute canine polyradiculoneuritis","volume":"18","author":"Rupp","year":"2013","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/bs.pmbts.2017.12.010_bib0715","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1093\/brain\/109.6.1115","article-title":"An acute axonal form of Guillain\u2013Barre polyneuropathy","volume":"109","author":"Feasby","year":"1986","journal-title":"Brain"},{"key":"10.1016\/bs.pmbts.2017.12.010_bib0720","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1093\/brain\/118.3.577","article-title":"Guillain-Barre-syndrome in northern china: the spectrum of neuropathological changes in clinically defined cases","volume":"118","author":"Griffin","year":"1995","journal-title":"Brain"},{"issue":"1\u20132","key":"10.1016\/bs.pmbts.2017.12.010_bib0725","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jneuroim.2010.02.001","article-title":"Antibodies to gangliosides and ganglioside complexes in Guillain\u2013Barre syndrome and Fisher syndrome: mini-review","volume":"223","author":"Kaida","year":"2010","journal-title":"J Neuroimmunol"},{"issue":"2","key":"10.1016\/bs.pmbts.2017.12.010_bib0730","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/1531-8249(199902)45:2<168::AID-ANA6>3.0.CO;2-6","article-title":"Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain\u2013Barre syndrome","volume":"45","author":"Ho","year":"1999","journal-title":"Ann Neurol"},{"issue":"4","key":"10.1016\/bs.pmbts.2017.12.010_bib0735","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/ana.20222","article-title":"Ganglioside complexes as new target antigens in Guillain\u2013Barre syndrome","volume":"56","author":"Kaida","year":"2004","journal-title":"Ann Neurol"},{"issue":"6","key":"10.1016\/bs.pmbts.2017.12.010_bib0740","doi-asserted-by":"crossref","first-page":"e284","DOI":"10.1212\/NXI.0000000000000284","article-title":"Microarray screening of Guillain\u2013Barre syndrome sera for antibodies to glycolipid complexes","volume":"3","author":"Halstead","year":"2016","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"2","key":"10.1016\/bs.pmbts.2017.12.010_bib0745","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1136\/practneurol-2014-000937","article-title":"Mimics and chameleons in Guillain\u2013Barre and Miller Fisher syndromes","volume":"15","author":"Wakerley","year":"2015","journal-title":"Pract Neurol"},{"issue":"3","key":"10.1016\/bs.pmbts.2017.12.010_bib0750","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1136\/jnnp-2013-305397","article-title":"Pharyngeal-cervical-brachial variant of Guillain\u2013Barre syndrome","volume":"85","author":"Wakerley","year":"2014","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"8","key":"10.1016\/bs.pmbts.2017.12.010_bib0755","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1212\/WNL.0000000000002256","article-title":"Acute bulbar palsy as a variant of Guillain\u2013Barre syndrome","volume":"86","author":"Kim","year":"2016","journal-title":"Neurology"},{"issue":"1\u20132","key":"10.1016\/bs.pmbts.2017.12.010_bib0760","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jns.2004.01.005","article-title":"Clinical correlates of serum anti-GT1a IgG antibodies","volume":"219","author":"Nagashima","year":"2004","journal-title":"J Neurol Sci"},{"issue":"6","key":"10.1016\/bs.pmbts.2017.12.010_bib0765","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1136\/jnnp.61.6.649","article-title":"Acute oropharyngeal palsy is associated with antibodies to GQ1b and GT1a gangliosides","volume":"61","author":"O\u2019Leary","year":"1996","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"10.1016\/bs.pmbts.2017.12.010_bib0770","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1212\/01.wnl.0000317093.57106.33","article-title":"GD1b-specific antibody induces ataxia in Guillain\u2013Barre syndrome","volume":"71","author":"Kaida","year":"2008","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/bs.pmbts.2017.12.010_bib0775","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1212\/WNL.56.9.1227","article-title":"Guillain\u2013Barre syndrome associated with IgG monospecific to ganglioside GD1b","volume":"56","author":"Miyazaki","year":"2001","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/bs.pmbts.2017.12.010_bib0780","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1212\/WNL.44.12.2395","article-title":"Acute ataxic neuropathy with cross-reactive antibodies to GD1b and GD3 gangliosides","volume":"44","author":"Willison","year":"1994","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/bs.pmbts.2017.12.010_bib0785","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1056\/NEJM195607122550201","article-title":"An unusual variant of acute idiopathic polyneuritis (syndrome of ophthalmoplegia, ataxia and areflexia)","volume":"255","author":"Fisher","year":"1956","journal-title":"New Engl J Med"},{"issue":"9","key":"10.1016\/bs.pmbts.2017.12.010_bib0790","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nrneurol.2014.138","article-title":"Guillain\u2013Barre and Miller Fisher syndromes: new diagnostic classification","volume":"10","author":"Wakerley","year":"2014","journal-title":"Nat Rev Neurol"},{"issue":"1\u20132","key":"10.1016\/bs.pmbts.2017.12.010_bib0795","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0006-8993(96)01123-7","article-title":"Ganglioside composition of the human cranial nerves, with special reference to pathophysiology of Miller Fisher syndrome","volume":"745","author":"Chiba","year":"1997","journal-title":"Brain Res"},{"issue":"7","key":"10.1016\/bs.pmbts.2017.12.010_bib0800","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1167\/iovs.08-3333","article-title":"Immunolocalization of GQ1b and related gangliosides in human extraocular neuromuscular junctions and muscle spindles","volume":"50","author":"Liu","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"12","key":"10.1016\/bs.pmbts.2017.12.010_bib0805","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1136\/jnnp-2012-303060","article-title":"Nationwide survey of patients in Japan with Bickerstaff brainstem encephalitis: epidemiological and clinical characteristics","volume":"83","author":"Koga","year":"2012","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"Pt. 10","key":"10.1016\/bs.pmbts.2017.12.010_bib0810","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1093\/brain\/awg233","article-title":"Bickerstaff's brainstem encephalitis: clinical features of 62 cases and a subgroup associated with Guillain\u2013Barre syndrome","volume":"126","author":"Odaka","year":"2003","journal-title":"Brain"},{"issue":"1","key":"10.1016\/bs.pmbts.2017.12.010_bib0815","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1136\/jnnp.70.1.50","article-title":"Anti-GQ1b IgG antibody syndrome: clinical and immunological range","volume":"70","author":"Odaka","year":"2001","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"9","key":"10.1016\/bs.pmbts.2017.12.010_bib0820","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/nrneurol.2017.84","article-title":"Autoantibodies in chronic inflammatory neuropathies: diagnostic and therapeutic implications","volume":"13","author":"Querol","year":"2017","journal-title":"Nat Rev Neurol"},{"issue":"4","key":"10.1016\/bs.pmbts.2017.12.010_bib0825","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1212\/WNL.48.4.1104","article-title":"Multifocal motor neuropathy: serum IgM binding to a GM1 ganglioside-containing lipid mixture but not to GM1 alone","volume":"48","author":"Pestronk","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/bs.pmbts.2017.12.010_bib0830","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jneuroim.2014.11.001","article-title":"Improving the detection of IgM antibodies against glycolipids complexes of GM1 and galactocerebroside in multifocal motor neuropathy using glycoarray and ELISA assays","volume":"278","author":"Delmont","year":"2015","journal-title":"J Neuroimmunol"},{"issue":"1","key":"10.1016\/bs.pmbts.2017.12.010_bib0835","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1468-1331.2012.03767.x","article-title":"Antibodies to heteromeric glycolipid complexes in multifocal motor neuropathy","volume":"20","author":"Galban-Horcajo","year":"2013","journal-title":"Eur J Neurol"},{"key":"10.1016\/bs.pmbts.2017.12.010_bib0840","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/ana.410360313","article-title":"Frequency and clinical correlates of anti-neural IgM antibodies in neuropathy associated with IgM monoclonal gammopathy","volume":"36","author":"Nobile-Orazio","year":"1994","journal-title":"Ann Neurol"},{"issue":"suppl","key":"10.1016\/bs.pmbts.2017.12.010_bib0845","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1002\/ana.410270709","article-title":"Autoimmune mechanisms in peripheral neuropathies","volume":"27","author":"Yu","year":"1990","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1016\/bs.pmbts.2017.12.010_bib0850","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1212\/WNL.56.2.228","article-title":"Neuropathy and IgM M-proteins: prognostic value of antibodies to MAG, SGPG, and sulfatide","volume":"56","author":"Eurelings","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/bs.pmbts.2017.12.010_bib0855","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1212\/WNL.37.2.242","article-title":"Experimental demyelination of nerve induced by serum of patients with neuropathy and an anti MAG IgM M protein","volume":"37","author":"Hays","year":"1987","journal-title":"Neurology"},{"key":"10.1016\/bs.pmbts.2017.12.010_bib0860","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1002\/mus.880111111","article-title":"Demyelination induced by intraneural injection of human anti MAG antibodies","volume":"11","author":"Willison","year":"1988","journal-title":"Muscle Nerve"},{"issue":"5","key":"10.1016\/bs.pmbts.2017.12.010_bib0865","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1172\/JCI118529","article-title":"A somatically mutated human antiganglioside IgM antibody that induces experimental neuropathy in mice is encoded by the variable region heavy chain gene, V1-18","volume":"97","author":"Willison","year":"1996","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1016\/bs.pmbts.2017.12.010_bib0870","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1002\/(SICI)1097-4547(19970315)47:6<636::AID-JNR9>3.0.CO;2-E","article-title":"Factors defining target specificity in antibody-mediated neuropathy: density-dependent binding of anti-GD1a polyclonal IgG from a neurological patient","volume":"47","author":"Kremer","year":"1997","journal-title":"J Neurosci Res"},{"issue":"2","key":"10.1016\/bs.pmbts.2017.12.010_bib0875","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0022-1759(97)00041-0","article-title":"Liposomes and immunoassays","volume":"204","author":"Rongen","year":"1997","journal-title":"J Immunol Methods"},{"key":"10.1016\/bs.pmbts.2017.12.010_bib0880","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.cbpa.2014.01.008","article-title":"The application of glycosphingolipid arrays to autoantibody detection in neuroimmunological disorders","volume":"18","author":"Galban-Horcajo","year":"2014","journal-title":"Curr Opin Chem Biol"},{"key":"10.1016\/bs.pmbts.2017.12.010_bib0885","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1046\/j.1468-1331.1999.610071.x","article-title":"Inter-laboratory validation of an ELISA for the determination of serum anti-ganglioside antibodies","volume":"6","author":"Willison","year":"1999","journal-title":"Eur J Neurol"},{"issue":"16","key":"10.1016\/bs.pmbts.2017.12.010_bib0890","doi-asserted-by":"crossref","first-page":"7390","DOI":"10.1073\/pnas.91.16.7390","article-title":"Selectin ligands","volume":"91","author":"Varki","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"issue":"Pt. 7","key":"10.1016\/bs.pmbts.2017.12.010_bib0895","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1093\/brain\/awn074","article-title":"Structural requirements of anti-GD1a antibodies determine their target specificity","volume":"131","author":"Lopez","year":"2008","journal-title":"Brain"},{"issue":"3","key":"10.1016\/bs.pmbts.2017.12.010_bib0900","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.bbadis.2005.11.005","article-title":"A new type of anti-ganglioside antibodies present in neurological patients","volume":"1762","author":"Lopez","year":"2006","journal-title":"Biochimica et Bbiophysica Acta"},{"issue":"3","key":"10.1016\/bs.pmbts.2017.12.010_bib0905","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.coi.2011.03.004","article-title":"T cell-independent B cell memory","volume":"23","author":"Defrance","year":"2011","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/bs.pmbts.2017.12.010_bib0910","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.it.2013.05.001","article-title":"Glycolipid antigens and autoantibodies in autoimmune neuropathies","volume":"34","author":"Willison","year":"2013","journal-title":"Trends Immunol"},{"key":"10.1016\/bs.pmbts.2017.12.010_bib0915","doi-asserted-by":"crossref","first-page":"S150","DOI":"10.1086\/513800","article-title":"Molecular mimicry between gangliosides and lipopolysaccharides of Campylobacter jejuni isolated from patients with Guillain\u2013Barre syndrome and Miller Fisher syndrome","volume":"176","author":"Yuki","year":"1997","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/bs.pmbts.2017.12.010_bib0920","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/mus.20762","article-title":"Ganglioside mimicry and peripheral nerve disease","volume":"35","author":"Yuki","year":"2007","journal-title":"Muscle Nerve"},{"issue":"4","key":"10.1016\/bs.pmbts.2017.12.010_bib0925","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1212\/WNL.51.4.1110","article-title":"The spectrum of antecedent infections in Guillain\u2013Barre syndrome: a case-control study","volume":"51","author":"Jacobs","year":"1998","journal-title":"Neurology"},{"issue":"suppl 1","key":"10.1016\/bs.pmbts.2017.12.010_bib0930","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1471-4159.2007.04707.x","article-title":"Campylobacter sialyltransferase gene polymorphism directs clinical features of Guillain\u2013Barre syndrome","volume":"103","author":"Yuki","year":"2007","journal-title":"J Neurochem"},{"issue":"31","key":"10.1016\/bs.pmbts.2017.12.010_bib0935","doi-asserted-by":"crossref","first-page":"11404","DOI":"10.1073\/pnas.0402391101","article-title":"Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain\u2013Barre syndrome","volume":"101","author":"Yuki","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"10.1016\/bs.pmbts.2017.12.010_bib0940","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1136\/jnnp.66.3.376","article-title":"Antiganglioside antibodies in Guillain\u2013Barre syndrome after a recent cytomegalovirus infection","volume":"66","author":"Khalili-Shirazi","year":"1999","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"10.1016\/bs.pmbts.2017.12.010_bib0945","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1212\/WNL.47.3.668","article-title":"Cytomegalovirus infection and Guillain\u2013Barre syndrome: the clinical, electrophysiologic, and prognostic features. Dutch Guillain\u2013Barre Study Group","volume":"47","author":"Visser","year":"1996","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/bs.pmbts.2017.12.010_bib1015","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1212\/WNL.57.4.736","article-title":"Anti-Gal-C antibodies in GBS subsequent to mycoplasma infection: evidence of molecular mimicry","volume":"57","author":"Kusunoki","year":"2001","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/bs.pmbts.2017.12.010_bib0955","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1212\/WNL.52.6.1282","article-title":"Haemophilus influenzae has a GM1 ganglioside-like structure and elicits Guillain\u2013Barre syndrome","volume":"52","author":"Mori","year":"1999","journal-title":"Neurology"},{"issue":"Pt. 10","key":"10.1016\/bs.pmbts.2017.12.010_bib0960","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1093\/brain\/123.10.2171","article-title":"Haemophilus influenzae infection and Guillain\u2013Barre syndrome","volume":"123","author":"Mori","year":"2000","journal-title":"Brain"},{"issue":"2","key":"10.1016\/bs.pmbts.2017.12.010_bib0965","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/ana.410380214","article-title":"Acute axonal Guillain\u2013Barre syndrome with IgG antibodies against motor axons following parenteral gangliosides","volume":"38","author":"Illa","year":"1995","journal-title":"Ann Neurol"},{"issue":"3","key":"10.1016\/bs.pmbts.2017.12.010_bib0970","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1055\/s-0031-1287655","article-title":"Vaccines and neurologic disease","volume":"31","author":"Sejvar","year":"2011","journal-title":"Seminars Neurol"},{"issue":"2","key":"10.1016\/bs.pmbts.2017.12.010_bib0975","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0304-3940(76)90033-1","article-title":"Ganglioside syndrome, a new autoimmune neurologic disorder, experimentally induced with brain gangliosides","volume":"2","author":"Nagai","year":"1976","journal-title":"Neurosci Lett"},{"key":"10.1016\/bs.pmbts.2017.12.010_bib0980","first-page":"86","article-title":"Ultrastructural study of central nervous system demyelination in galactocerebroside sensitized rabbits","volume":"55","author":"Goban","year":"1986","journal-title":"Lab Invest"},{"issue":"1","key":"10.1016\/bs.pmbts.2017.12.010_bib0985","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0304-3940(99)00621-7","article-title":"Degeneration of rabbit sensory neurons induced by passive transfer of anti-GD1b antiserum","volume":"273","author":"Kusunoki","year":"1999","journal-title":"Neurosci Lett"},{"issue":"4","key":"10.1016\/bs.pmbts.2017.12.010_bib0990","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1093\/brain\/awx012","article-title":"Co-cultures with stem cell-derived human sensory neurons reveal regulators of peripheral myelination","volume":"140","author":"Clark","year":"2017","journal-title":"Brain"},{"issue":"3","key":"10.1016\/bs.pmbts.2017.12.010_bib0995","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/ana.33333","article-title":"Acute motor axonal neuropathy rabbit model: immune attack on nerve root axons","volume":"54","author":"Susuki","year":"2003","journal-title":"Ann Neurol"},{"issue":"6","key":"10.1016\/bs.pmbts.2017.12.010_bib1000","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1172\/JCI6837","article-title":"Monoclonal antibodies raised against Guillain\u2013Barre syndrome-associated Campylobacter jejuni lipopolysaccharides react with neuronal gangliosides and paralyze muscle-nerve preparations","volume":"104","author":"Goodyear","year":"1999","journal-title":"J Clin Invest"},{"issue":"Pt. 16","key":"10.1016\/bs.pmbts.2017.12.010_bib1005","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1113\/jphysiol.2009.171702","article-title":"Pathophysiological actions of neuropathy-related anti-ganglioside antibodies at the neuromuscular junction","volume":"587","author":"Plomp","year":"2009","journal-title":"J Physiol"},{"issue":"1","key":"10.1016\/bs.pmbts.2017.12.010_bib1010","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/jns.12194","article-title":"Inhibition of complement in Guillain\u2013Barre syndrome: the ICA-GBS study","volume":"22","author":"Davidson","year":"2017","journal-title":"J Peripher Nerv Syst"}],"container-title":["Progress in Molecular Biology and Translational Science","Gangliosides in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877117317302156?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877117317302156?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T06:24:52Z","timestamp":1660717492000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877117317302156"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"ISBN":["9780128123416"],"references-count":101,"URL":"https:\/\/doi.org\/10.1016\/bs.pmbts.2017.12.010","relation":{},"ISSN":["1877-1173"],"issn-type":[{"value":"1877-1173","type":"print"}],"subject":[],"published":{"date-parts":[[2018]]}}}